Reaction

Loss Of Control Of Legs reporting signals

Last recalculated 2026-09-14T18:28:35.993900+00:00 · 3,773 reports · 33 co-occurring drugs

As of the last recalculation, Loss Of Control Of Legs appears in 3,773 FAERS reports alongside 33 co-occurring drug terms. The strongest observed disproportionality signal is NATALIZUMAB (PRR 44.6).

Important: FAERS is a spontaneous, voluntary, unverified reporting system. PRR and ROR identify reporting patterns for investigation; they are not incidence rates and do not establish causation.
DrugCo-reportsPRRROR
Natalizumab1,06544.644.9
Interferon Beta-1A95736.336.4
Diroximel Fumarate5023.423.5
Dimethyl Fumarate41520.820.9
Peginterferon Beta-1A4820.420.5
Pravastatin Sodium4111.511.6
Dalfampridine14211.311.3
Ticagrelor427.37.3
Baclofen1056.96.9
Amantadine165.75.7
Candesartan355.55.5
Irbesartan405.05.0
Quinapril Hydrochloride74.94.9
Duloxetine584.64.7
Siponimod74.34.3
Tizanidine Hydrochloride144.34.3
Teriflunomide313.83.8
Oxybutynin Chloride63.83.8
Tizanidine153.53.5
Interferon Beta-1B123.53.5
Glatiramer Acetate373.43.4
Ofatumumab203.33.3
Sotalol Hydrochloride103.33.3
Atorvastatin Calcium, Film Coated413.23.2
Vilazodone Hydrochloride42.42.4
Fingolimod Hcl342.22.2
Iohexol32.02.0
Cenobamate32.02.0
Droxidopa71.81.8
Apalutamide31.41.4
Tafamidis31.41.4
Pimavanserin Tartrate141.41.4
Voxelotor30.70.7

Related reactions

Data source: openFDA FAERS. See the OpenPV methodology and limitations.